Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry

Science

Volumn 276, Issue 5320, 1997, Pages 1874-1878

  Pleskoff, Olivier ^a   Tréboute, Carole ^a   Brelot, Anne ^a   Heveker, Nikolaus ^a   Seman, Michel ^b   Alizon, Marc ^a  

^a INSTITUT COCHIN   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; INTERNALIZATION; NONHUMAN; PRIORITY JOURNAL; VIRUS EXPRESSION; VIRUS INFECTIVITY; VIRUS TRANSMISSION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; AMINO ACID SEQUENCE; CELL FUSION; CHEMOKINES; COCULTURE TECHNIQUES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GIANT CELLS; HELA CELLS; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; RECEPTORS, CXCR4; RECEPTORS, CYTOKINE; RECEPTORS, HIV; TRANSFECTION; TUMOR CELLS, CULTURED; VIRAL PROTEINS;

EID: 1842287973     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.276.5320.1874     Document Type: Article

References (74)

1. J. P. Moore, B. A. Jameson, R. A. Weiss, Q. J. Sattentau, in Viral Fusion Mechanisms, J. Bentz, Ed. (CRC Press, Boca Raton, FL, 1993), pp. 233-289; P. Bates, Cell 86, 1 (1996); M. P. D'Souza and V. A. Harden, Nature Med. 2, 1293 (1996); C. C. Broder and D. S. Dimitrov, Pathobiology 64, 171 (1996).
2. J. P. Moore, B. A. Jameson, R. A. Weiss, Q. J. Sattentau, in Viral Fusion Mechanisms, J. Bentz, Ed. (CRC Press, Boca Raton, FL, 1993), pp. 233-289; P. Bates, Cell 86, 1 (1996); M. P. D'Souza and V. A. Harden, Nature Med. 2, 1293 (1996); C. C. Broder and D. S. Dimitrov, Pathobiology 64, 171 (1996).
3. J. P. Moore, B. A. Jameson, R. A. Weiss, Q. J. Sattentau, in Viral Fusion Mechanisms, J. Bentz, Ed. (CRC Press, Boca Raton, FL, 1993), pp. 233-289; P. Bates, Cell 86, 1 (1996); M. P. D'Souza and V. A. Harden, Nature Med. 2, 1293 (1996); C. C. Broder and D. S. Dimitrov, Pathobiology 64, 171 (1996).
4. J. P. Moore, B. A. Jameson, R. A. Weiss, Q. J. Sattentau, in Viral Fusion Mechanisms, J. Bentz, Ed. (CRC Press, Boca Raton, FL, 1993), pp. 233-289; P. Bates, Cell 86, 1 (1996); M. P. D'Souza and V. A. Harden, Nature Med. 2, 1293 (1996); C. C. Broder and D. S. Dimitrov, Pathobiology 64, 171 (1996).
5. Y. Feng, C. C. Broder, P. E. Kennedy, E. A. Berger, Science 272, 872 (1996).
6. C. C. Bleul et al., Nature 382, 829 (1996); E. Oberlin et al., ibid., p. 833.
7. C. C. Bleul et al., Nature 382, 829 (1996); E. Oberlin et al., ibid., p. 833.
8. F. Cocchi et al., Science 270, 1811 (1995).
9. H. Deng et al., Nature 381, 661 (1996).
10. T. Dragic et al., ibid., p. 667; G. Alkhatib et al., Science 272, 1955 (1996); L. Wu et al., Nature 384, 179 (1996); A. Trkola et al., ibid., p. 184.
11. T. Dragic et al., ibid., p. 667; G. Alkhatib et al., Science 272, 1955 (1996); L. Wu et al., Nature 384, 179 (1996); A. Trkola et al., ibid., p. 184.
12. T. Dragic et al., ibid., p. 667; G. Alkhatib et al., Science 272, 1955 (1996); L. Wu et al., Nature 384, 179 (1996); A. Trkola et al., ibid., p. 184.
13. T. Dragic et al., ibid., p. 667; G. Alkhatib et al., Science 272, 1955 (1996); L. Wu et al., Nature 384, 179 (1996); A. Trkola et al., ibid., p. 184.
14. H. Choe et al., Cell 85, 1135 (1996).
15. B. J. Doranz et al., ibid., p. 1149.
16. L. Zhang, Y. Huang, T. He, Y. Cao, D. D. Ho, Nature 383, 768 (1996); G. Simmons et al., J. Virol. 70, 8355 (1996).
17. L. Zhang, Y. Huang, T. He, Y. Cao, D. D. Ho, Nature 383, 768 (1996); G. Simmons et al., J. Virol. 70, 8355 (1996).
18. J. He et al., Nature 385, 645 (1997).
19. R. Liu et al., Cell 86, 367 (1996); M. Samson et al., Nature 382, 722 (1996); M. Dean et al., Science 273, 1856 (1996).
20. R. Liu et al., Cell 86, 367 (1996); M. Samson et al., Nature 382, 722 (1996); M. Dean et al., Science 273, 1856 (1996).
21. R. Liu et al., Cell 86, 367 (1996); M. Samson et al., Nature 382, 722 (1996); M. Dean et al., Science 273, 1856 (1996).
22. O. Pleskoff, N. Sol, B. Labrosse, M. Alizon, J. Virol. 71, 3259 (1997).
23. M. J. Endres et al., Cell 87, 745 (1996); Z. Chen, P. Zhou, D. D. Ho, N. R. Landau, P. A. Marx, J. Virol. 71, 2705 (1997); O. Pleskoff et al., unpublished results.
24. M. J. Endres et al., Cell 87, 745 (1996); Z. Chen, P. Zhou, D. D. Ho, N. R. Landau, P. A. Marx, J. Virol. 71, 2705 (1997); O. Pleskoff et al., unpublished results.
25. M. J. Endres et al., Cell 87, 745 (1996); Z. Chen, P. Zhou, D. D. Ho, N. R. Landau, P. A. Marx, J. Virol. 71, 2705 (1997); O. Pleskoff et al., unpublished results.
26. S. K. Ahuja and P. M. Murphy, J. Biol. Chem. 268, 20691 (1993); J. Nicholas, J. Virol. 70, 5975 (1996); W. D. Rawlinson, H. E. Farrell, B. G. Barrel, ibid., p. 8833; L. Arvanitakis, E. Geras-Raaka, A. Varma, M. C. Gershengorn, E. Cesarman, Nature 385, 347 (1997).
27. S. K. Ahuja and P. M. Murphy, J. Biol. Chem. 268, 20691 (1993); J. Nicholas, J. Virol. 70, 5975 (1996); W. D. Rawlinson, H. E. Farrell, B. G. Barrel, ibid., p. 8833; L. Arvanitakis, E. Geras-Raaka, A. Varma, M. C. Gershengorn, E. Cesarman, Nature 385, 347 (1997).
28. S. K. Ahuja and P. M. Murphy, J. Biol. Chem. 268, 20691 (1993); J. Nicholas, J. Virol. 70, 5975 (1996); W. D. Rawlinson, H. E. Farrell, B. G. Barrel, ibid., p. 8833; L. Arvanitakis, E. Geras-Raaka, A. Varma, M. C. Gershengorn, E. Cesarman, Nature 385, 347 (1997).
29. S. K. Ahuja and P. M. Murphy, J. Biol. Chem. 268, 20691 (1993); J. Nicholas, J. Virol. 70, 5975 (1996); W. D. Rawlinson, H. E. Farrell, B. G. Barrel, ibid., p. 8833; L. Arvanitakis, E. Geras-Raaka, A. Varma, M. C. Gershengorn, E. Cesarman, Nature 385, 347 (1997).
30. M. S. Chee, S. C. Satchwell, E. Preddie, K. M. Weston, B. G. Barrell, Nature 344, 774 (1990).
31. A. R. Welch, L. M. McGregor, W. Gibson, J. Virol. 65, 3915 (1991).
32. K. Neote, D. DiGregorio, J. Y. Mak, R. Horuk, T. J. Schall, Cell 72, 415 (1993); J.-L. Gao and P. M. Murphy, J. Biol. Chem. 269, 28539 (1994).
33. K. Neote, D. DiGregorio, J. Y. Mak, R. Horuk, T. J. Schall, Cell 72, 415 (1993); J.-L. Gao and P. M. Murphy, J. Biol. Chem. 269, 28539 (1994).
34. R. Harrington and A. P. Geballe, J. Virol. 67, 5939 (1993).
35. + cells, or for infection with HIV, as described (12).
36. O. Schwartz, M. Alizon, J. M. Heard, O. Danos, Virology 198, 360 (1994).
37. P. Westervelt, H. E. Gendelman, L. Ratner, Proc. Natl. Acad. Sci. U.S.A. 88, 3097 (1991). The env gene of LAI in the pMA243 vector was replaced with ADA env (20) with the use of common Kpn I and Ava I sites. The resulting vector was introduced into HeLa cells, and clones were selected with 2 μM methotrexate, as described (20).
38. F. Brun-Vézinet et al., Lancet i, 128 (1987).
39. LAI provirus [K. Peden, M. Emerman, L. Montagnier, Virology 185, 661 (1991)] in which the env gene had been replaced with ADA env. Proviruses were introduced into HeLa cells by calcium phosphate precipitation. Cell-free supernatants were harvested 2 to 3 days after transfection, and p24 antigen concentration was assayed.
40. LAI provirus [K. Peden, M. Emerman, L. Montagnier, Virology 185, 661 (1991)] in which the env gene had been replaced with ADA env. Proviruses were introduced into HeLa cells by calcium phosphate precipitation. Cell-free supernatants were harvested 2 to 3 days after transfection, and p24 antigen concentration was assayed.
41. LAI were produced from chronically infected CEM cells (12).
42. F. Clavel and P. Charneau, J. Virol. 68, 1179 (1994).
43. All chemokine receptors and homologs were expressed from the Rc/CMV vector. The US27 and UL33 ORFs were amplified by PCR from CMV-infected cells. Five independent clones were tested for each ORF.
44. G. I. Evan, G. K. Lewis, G. Ramsay, J. M. Bishop, Mol. Cell. Biol. 5, 3610 (1985). A pCDNA3 vector (Clontech, Palo Alto, CA) engineered to express the 16-amino acid sequence Met-Gly-Pro-Glu-Gln-Lys-Leu-Ile-Ser-Glu-Glu-Asp-Leu-Gly-Ser-Gly, which contains the epitope recognized by the 9E10 monoclonal antibody to human c-MYC (pCDNA-tag), was further modifed by inserting the CXCR4, CCR5, or US28 coding sequences (excluding the initiation codon) downstream of the epitope sequence at a Bam HI site, either by blunt-end ligation with a filled-in Nco I site (CXCR4) or by creating a Bam HI site with PCR primers (US28 and CCR5).
45. HeLa-P4 cells were cotransfected (6:1 ratio) with vectors encoding epitope-tagged receptors and EGFP-N1 (Clontech), which encodes the green fluorescent protein. Cells were detached with phosphate-buffered saline containing 1 mM EDTA 36 hours after transfection, and then stained with the 9E10 monoclonal antibody (4 μg/ml) (Boehringer, Mannheim, Germany) and phycoerythrin-conjugated goat antibodies to mouse immunoglobulin G (16 μg/ ml) (Dako, Glostrup, Denmark). Fixed cells were analyzed for green and red fluorescence with an Epics Elite flow cytometer (Coultronics).
46. HeLa-P4 cells were cotransfected by calcium phosphate precipitation with a hygromycin-resistance vector (SV-hygro) and either Rc/CMV-CCR5 or Rc/CMV-US28 (1:20 ratio). Cell clones were selected in the presence of hygromycin B (150 μg/ml).
47. We performed the experiments essentially as described (2). Simian COS cells or HeLa cells were cotransfected with Rc/CMV vectors containing the CXCR4, CCR5, or US28 ORFs (cloned downstream of the T7 promoter) and Rc/CMV-CD4, and were infected with vT7pol. Cocultures were then performed with HeLa-Env/ADA or HeLa-Env/LAI cells transiently transfected with a T7-lacZ construct.
48. J. B. Jackson, A. Erice, J. A. Englund, J. R. Edson, H. H. Balfour, Transfusion 28, 187 (1988); C. A. Wiley and J. A. Nelson, Am. J. Pathol. 133, 73 (1988); A. Webster et al., Lancet ii, 63 (1989); J. A. Nelson, P. Ghazal, C. A. Wiley, AIDS 4, 1 (1990); A. Webster et al., Clin. Exp. Immunol. 88, 6 (1992); C. T. Leach et al., J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 6, 407 (1993); C. A. Sabin et al., Epidemiol. Infect. 114, 361 (1995).
49. J. B. Jackson, A. Erice, J. A. Englund, J. R. Edson, H. H. Balfour, Transfusion 28, 187 (1988); C. A. Wiley and J. A. Nelson, Am. J. Pathol. 133, 73 (1988); A. Webster et al., Lancet ii, 63 (1989); J. A. Nelson, P. Ghazal, C. A. Wiley, AIDS 4, 1 (1990); A. Webster et al., Clin. Exp. Immunol. 88, 6 (1992); C. T. Leach et al., J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 6, 407 (1993); C. A. Sabin et al., Epidemiol. Infect. 114, 361 (1995).
50. J. B. Jackson, A. Erice, J. A. Englund, J. R. Edson, H. H. Balfour, Transfusion 28, 187 (1988); C. A. Wiley and J. A. Nelson, Am. J. Pathol. 133, 73 (1988); A. Webster et al., Lancet ii, 63 (1989); J. A. Nelson, P. Ghazal, C. A. Wiley, AIDS 4, 1 (1990); A. Webster et al., Clin. Exp. Immunol. 88, 6 (1992); C. T. Leach et al., J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 6, 407 (1993); C. A. Sabin et al., Epidemiol. Infect. 114, 361 (1995).
51. J. B. Jackson, A. Erice, J. A. Englund, J. R. Edson, H. H. Balfour, Transfusion 28, 187 (1988); C. A. Wiley and J. A. Nelson, Am. J. Pathol. 133, 73 (1988); A. Webster et al., Lancet ii, 63 (1989); J. A. Nelson, P. Ghazal, C. A. Wiley, AIDS 4, 1 (1990); A. Webster et al., Clin. Exp. Immunol. 88, 6 (1992); C. T. Leach et al., J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 6, 407 (1993); C. A. Sabin et al., Epidemiol. Infect. 114, 361 (1995).
52. J. B. Jackson, A. Erice, J. A. Englund, J. R. Edson, H. H. Balfour, Transfusion 28, 187 (1988); C. A. Wiley and J. A. Nelson, Am. J. Pathol. 133, 73 (1988); A. Webster et al., Lancet ii, 63 (1989); J. A. Nelson, P. Ghazal, C. A. Wiley, AIDS 4, 1 (1990); A. Webster et al., Clin. Exp. Immunol. 88, 6 (1992); C. T. Leach et al., J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 6, 407 (1993); C. A. Sabin et al., Epidemiol. Infect. 114, 361 (1995).
53. J. B. Jackson, A. Erice, J. A. Englund, J. R. Edson, H. H. Balfour, Transfusion 28, 187 (1988); C. A. Wiley and J. A. Nelson, Am. J. Pathol. 133, 73 (1988); A. Webster et al., Lancet ii, 63 (1989); J. A. Nelson, P. Ghazal, C. A. Wiley, AIDS 4, 1 (1990); A. Webster et al., Clin. Exp. Immunol. 88, 6 (1992); C. T. Leach et al., J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 6, 407 (1993); C. A. Sabin et al., Epidemiol. Infect. 114, 361 (1995).
54. J. B. Jackson, A. Erice, J. A. Englund, J. R. Edson, H. H. Balfour, Transfusion 28, 187 (1988); C. A. Wiley and J. A. Nelson, Am. J. Pathol. 133, 73 (1988); A. Webster et al., Lancet ii, 63 (1989); J. A. Nelson, P. Ghazal, C. A. Wiley, AIDS 4, 1 (1990); A. Webster et al., Clin. Exp. Immunol. 88, 6 (1992); C. T. Leach et al., J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 6, 407 (1993); C. A. Sabin et al., Epidemiol. Infect. 114, 361 (1995).
55. P. R. Becherer et al., Am. J. Hematol. 34, 204 (1990); C. S. Rabkin et al., J. Infect. Dis. 168, 1260 (1993).
56. P. R. Becherer et al., Am. J. Hematol. 34, 204 (1990); C. S. Rabkin et al., J. Infect. Dis. 168, 1260 (1993).
57. G. P. A. Rice, R. D. Schrier, M. B. A. Oldstone, Proc. Natl. Acad. Sci. U.S.A. 81, 6134 (1984); R. D. Schrier, J. A. Nelson, M. B. A. Oldstone, Science 230, 1048 (1985); R. W. Braun and H. C. Reiser, J. Virol. 60, 29 (1986); C. E. Ibanez, R. Schrier, P. Ghazal, C. Wiley, J. A. Nelson, ibid. 65, 6581 (1991).
58. G. P. A. Rice, R. D. Schrier, M. B. A. Oldstone, Proc. Natl. Acad. Sci. U.S.A. 81, 6134 (1984); R. D. Schrier, J. A. Nelson, M. B. A. Oldstone, Science 230, 1048 (1985); R. W. Braun and H. C. Reiser, J. Virol. 60, 29 (1986); C. E. Ibanez, R. Schrier, P. Ghazal, C. Wiley, J. A. Nelson, ibid. 65, 6581 (1991).
59. G. P. A. Rice, R. D. Schrier, M. B. A. Oldstone, Proc. Natl. Acad. Sci. U.S.A. 81, 6134 (1984); R. D. Schrier, J. A. Nelson, M. B. A. Oldstone, Science 230, 1048 (1985); R. W. Braun and H. C. Reiser, J. Virol. 60, 29 (1986); C. E. Ibanez, R. Schrier, P. Ghazal, C. Wiley, J. A. Nelson, ibid. 65, 6581 (1991).
60. G. P. A. Rice, R. D. Schrier, M. B. A. Oldstone, Proc. Natl. Acad. Sci. U.S.A. 81, 6134 (1984); R. D. Schrier, J. A. Nelson, M. B. A. Oldstone, Science 230, 1048 (1985); R. W. Braun and H. C. Reiser, J. Virol. 60, 29 (1986); C. E. Ibanez, R. Schrier, P. Ghazal, C. Wiley, J. A. Nelson, ibid. 65, 6581 (1991).
61. M. Samson, O. Labbe, C. Mollereau, G. Vassart, M. Parmentier, Biochemistry 35, 3362 (1996).
62. J. A. Nelson, C. Reynolds-Kohler, M. B. A. Oldstone, C. A. Wiley, Virology 165, 286 (1988); C. Finkle, M. A. Tapper, K. K. Knox, D. R. Carrigan, J. Acquired Immune Defic. Syndr. 4, 735 (1991); P. R. Skolnik et al., Am. J. Ophthalmol. 107, 361 (1989).
63. J. A. Nelson, C. Reynolds-Kohler, M. B. A. Oldstone, C. A. Wiley, Virology 165, 286 (1988); C. Finkle, M. A. Tapper, K. K. Knox, D. R. Carrigan, J. Acquired Immune Defic. Syndr. 4, 735 (1991); P. R. Skolnik et al., Am. J. Ophthalmol. 107, 361 (1989).
64. J. A. Nelson, C. Reynolds-Kohler, M. B. A. Oldstone, C. A. Wiley, Virology 165, 286 (1988); C. Finkle, M. A. Tapper, K. K. Knox, D. R. Carrigan, J. Acquired Immune Defic. Syndr. 4, 735 (1991); P. R. Skolnik et al., Am. J. Ophthalmol. 107, 361 (1989).
65. P. R. Skolnik, B. R. Kostoff, M. S. Hirsch, J. Infect. Dis. 157, 508 (1988); R. F. Rando, A. Srinivasan, J. Feingold, E. Gonczol, S. Plotkin, Virology 176, 87 (1990); W. Ho et al., J. Gen. Virol. 71, 97 (1990); W. Ho, L. Song, S. D. Douglas, J. Acquired Immune Defic. Syndr. 4, 1098 (1991); G. Hirka et al., J. Virol. 65, 2732 (1991).
66. P. R. Skolnik, B. R. Kostoff, M. S. Hirsch, J. Infect. Dis. 157, 508 (1988); R. F. Rando, A. Srinivasan, J. Feingold, E. Gonczol, S. Plotkin, Virology 176, 87 (1990); W. Ho et al., J. Gen. Virol. 71, 97 (1990); W. Ho, L. Song, S. D. Douglas, J. Acquired Immune Defic. Syndr. 4, 1098 (1991); G. Hirka et al., J. Virol. 65, 2732 (1991).
67. P. R. Skolnik, B. R. Kostoff, M. S. Hirsch, J. Infect. Dis. 157, 508 (1988); R. F. Rando, A. Srinivasan, J. Feingold, E. Gonczol, S. Plotkin, Virology 176, 87 (1990); W. Ho et al., J. Gen. Virol. 71, 97 (1990); W. Ho, L. Song, S. D. Douglas, J. Acquired Immune Defic. Syndr. 4, 1098 (1991); G. Hirka et al., J. Virol. 65, 2732 (1991).
68. P. R. Skolnik, B. R. Kostoff, M. S. Hirsch, J. Infect. Dis. 157, 508 (1988); R. F. Rando, A. Srinivasan, J. Feingold, E. Gonczol, S. Plotkin, Virology 176, 87 (1990); W. Ho et al., J. Gen. Virol. 71, 97 (1990); W. Ho, L. Song, S. D. Douglas, J. Acquired Immune Defic. Syndr. 4, 1098 (1991); G. Hirka et al., J. Virol. 65, 2732 (1991).
69. P. R. Skolnik, B. R. Kostoff, M. S. Hirsch, J. Infect. Dis. 157, 508 (1988); R. F. Rando, A. Srinivasan, J. Feingold, E. Gonczol, S. Plotkin, Virology 176, 87 (1990); W. Ho et al., J. Gen. Virol. 71, 97 (1990); W. Ho, L. Song, S. D. Douglas, J. Acquired Immune Defic. Syndr. 4, 1098 (1991); G. Hirka et al., J. Virol. 65, 2732 (1991).
70. J. L. Lathey, D. H. Spector, S. A. Spector, Virology 199, 98 (1994).
71. F. D. Toth et al., J. Virol. 69, 2223 (1995).
72. V. Koval, C. Clark, M. Vaishnav, S. A. Spector, D. H. Spector, ibid. 65, 6969 (1991); F. M. Jault, S. A. Spector, D. H. Spector, ibid. 68, 959 (1994).
73. V. Koval, C. Clark, M. Vaishnav, S. A. Spector, D. H. Spector, ibid. 65, 6969 (1991); F. M. Jault, S. A. Spector, D. H. Spector, ibid. 68, 959 (1994).
74. We thank F. Letourneur and I. Bouchaert for assistance with DNA sequencing and flow cytometry; C. Nahmias for the c-MYC epitope vector; Y. Henin and Q. Sattentau for HIV-1 strains; and J. Richardson, S. Michelson, and J. J. Kupiec for comments on the manuscript. Supported by the Agence Nationale de Recherches sur le SIDA and by fellowships to O.P. and N.H. from Ensemble contre le SIDA.